Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anterix (ATEX) EBT Margin (2016 - 2025)

Historic EBT Margin for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to 550.1%.

  • Anterix's EBT Margin fell 10274900.0% to 550.1% in Q4 2025 from the same period last year, while for Dec 2025 it was 1436.38%, marking a year-over-year increase of 19260900.0%. This contributed to the annual value of 157.19% for FY2025, which is 221200.0% up from last year.
  • Latest data reveals that Anterix reported EBT Margin of 550.1% as of Q4 2025, which was down 10274900.0% from 3933.89% recorded in Q3 2025.
  • In the past 5 years, Anterix's EBT Margin ranged from a high of 3933.89% in Q3 2025 and a low of 6518.68% during Q2 2021
  • For the 5-year period, Anterix's EBT Margin averaged around 1073.06%, with its median value being 782.74% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first soared by 58681800bps in 2023, then plummeted by -34182400bps in 2024.
  • Quarter analysis of 5 years shows Anterix's EBT Margin stood at 3195.58% in 2021, then surged by 58bps to 1351.21% in 2022, then skyrocketed by 110bps to 131.08% in 2023, then skyrocketed by 264bps to 477.39% in 2024, then crashed by -215bps to 550.1% in 2025.
  • Its EBT Margin was 550.1% in Q4 2025, compared to 3933.89% in Q3 2025 and 1616.57% in Q2 2025.